These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34244930)

  • 1. The association between maternal perfluoroalkyl substances exposure and early attention deficit hyperactivity disorder in children: a systematic review and meta-analysis.
    Qu A; Cao T; Li Z; Wang W; Liu R; Wang X; Nie Y; Sun S; Liu X; Zhang X
    Environ Sci Pollut Res Int; 2021 Dec; 28(47):67066-67081. PubMed ID: 34244930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between early-childhood exposure to perfluoroalkyl substances and ADHD symptoms: A prospective cohort study.
    Kim JI; Kim BN; Lee YA; Shin CH; Hong YC; Døssing LD; Hildebrandt G; Lim YH
    Sci Total Environ; 2023 Jun; 879():163081. PubMed ID: 36972880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies.
    Forns J; Verner MA; Iszatt N; Nowack N; Bach CC; Vrijheid M; Costa O; Andiarena A; Sovcikova E; Høyer BB; Wittsiepe J; Lopez-Espinosa MJ; Ibarluzea J; Hertz-Picciotto I; Toft G; Stigum H; Guxens M; Liew Z; Eggesbø M
    Environ Health Perspect; 2020 May; 128(5):57002. PubMed ID: 32378965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study.
    Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A
    Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoroalkyl substances in cord blood and attention deficit/hyperactivity disorder symptoms in seven-year-old children.
    Lien GW; Huang CC; Shiu JS; Chen MH; Hsieh WS; Guo YL; Chen PC
    Chemosphere; 2016 Aug; 156():118-127. PubMed ID: 27174824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-life exposure to persistent organic pollutants (OCPs, PBDEs, PCBs, PFASs) and attention-deficit/hyperactivity disorder: A multi-pollutant analysis of a Norwegian birth cohort.
    Lenters V; Iszatt N; Forns J; Čechová E; Kočan A; Legler J; Leonards P; Stigum H; Eggesbø M
    Environ Int; 2019 Apr; 125():33-42. PubMed ID: 30703609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhood.
    Ode A; Källén K; Gustafsson P; Rylander L; Jönsson BA; Olofsson P; Ivarsson SA; Lindh CH; Rignell-Hydbom A
    PLoS One; 2014; 9(4):e95891. PubMed ID: 24760015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption.
    Caron-Beaudoin É; Ayotte P; Blanchette C; Muckle G; Avard E; Ricard S; Lemire M
    Environ Int; 2020 Dec; 145():106169. PubMed ID: 33041046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between maternal and child PFAS concentrations and repeated measures of ADHD symptoms at age 2½ and 5 years in children from the Odense Child Cohort.
    Dalsager L; Jensen TK; Nielsen F; Grandjean P; Bilenberg N; Andersen HR
    Neurotoxicol Teratol; 2021; 88():107031. PubMed ID: 34563660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age.
    Hoffman K; Webster TF; Weisskopf MG; Weinberg J; Vieira VM
    Environ Health Perspect; 2010 Dec; 118(12):1762-7. PubMed ID: 20551004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense Child Cohort.
    Beck IH; Timmermann CAG; Nielsen F; Schoeters G; Jøhnk C; Kyhl HB; Høst A; Jensen TK
    Environ Health; 2019 Nov; 18(1):97. PubMed ID: 31730470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between per- and polyfluoroalkyl substances and risk of gestational diabetes mellitus.
    Wang J; Zhang J; Fan Y; Li Z; Tao C; Yan W; Niu R; Huang Y; Xu Q; Wang X; Xu Q; Han L; Lu C
    Int J Hyg Environ Health; 2022 Mar; 240():113904. PubMed ID: 34915280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies.
    Ballesteros V; Costa O; Iñiguez C; Fletcher T; Ballester F; Lopez-Espinosa MJ
    Environ Int; 2017 Feb; 99():15-28. PubMed ID: 27884404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.